Trials / Unknown
UnknownNCT03226314
Community Epidemiology and Typology of Third-generation Cephalosporins Resistant Enterobacteriaceae in Reunion Island
Community Epidemiology and Typology of Third-generation Cephalosporins Resistant Enterobacteriaceae (Prevalence, Resistance Mechanisms and Risk Factors) in Reunion Island
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (actual)
- Sponsor
- Centre Hospitalier Universitaire de la Réunion · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
In its report dated april 2014, World Health Organization confirms antibiotic resistance dissemination in all parts of the world, in hospitals and in community and worries about a possible comeback to a pre-antibiotic era during the 21st century. For the last 15 years, third-generation cephalosporins resistant enterobacteriaceae (3GCREB) prevalence is continuously increasing. Community 3GCREB prevalence has not been studied whereas several observations made in Reunion Island hospital suggest a diffusion in community. In this situation of world-wide and regional extension of bacterial resistance, the investigator offers to study bacterial resistance to antibiotic in Reunion Island community.
Detailed description
The investigator is focused on E. coli species exhibiting BLSE or metallo-betalactamases production that could be encountered du to the increasing level of migratory flow in Reunion Island. Fecal sample collection will be used for further investigations on bacterial typology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | stool sample | study will be proposed to all patients entering emergency ward or intensive care unit in Reunion Island university hospital. Upon consent, a stool sample will be taken (either directly on emitted stools or by rectal sampling) and analysed for enterobacteriaceae. |
Timeline
- Start date
- 2017-11-21
- Primary completion
- 2018-12-01
- Completion
- 2019-06-30
- First posted
- 2017-07-21
- Last updated
- 2019-03-07
Locations
1 site across 1 country: Reunion
Source: ClinicalTrials.gov record NCT03226314. Inclusion in this directory is not an endorsement.